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ABSTRACT
RELATIONSHIP BETWEEN BINGE EATING DISORDER
AND CIRCADIAN CHRONOTYPE
Leon B. Jons MD
UNIVERSITY OF NEBRASKA, 2018
Advisor: Laura Bilek, PhD

Binge eating disorder (BED) is a common condition in the general population and
is more common in individuals with obesity. The later timing of food intake has been
associated with an increase incidence of obesity. The purpose of this study was to
evaluate the relationship between circadian chronotype and BED in a population of
individuals with obesity. The sample consists of a retrospective review of 170 subjects
presenting to an obesity medicine clinic who had been clinically evaluated for BED and
chronotype.
No significant correlation was found between BED and a late chronotype in this
population. In a secondary analysis no significant difference in degree of weight loss
was related to the presence or absence of BED or an earlier or later chronotype. This
retrospective study does not support the relationship of binge eating disorder and
circadian chronotype.
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CHAPTER 1: INTRODUCTION

BINGE EATING DISORDER
Binge eating disorder (BED) is a common condition observed in obesity treatment programs. Lifetime prevalence of BED in the general population in the United
States is estimated to be 2.0-3.5%.1 BED is found in higher prevalence in individuals
seeking treatment of obesity and may impact the effectiveness of weight loss interventions.
BED was named as a diagnostic category in the Diagnostic and Statistical
Manual V (DSM-V). This disorder is characterized by recurrent episodes of binge eating
in which an individual eats a larger amount of food than normal in a discrete period of
time with a sense of lack of control. BED also requires at least one episode of binge
eating per week over the last three months. The binge eating episodes must cause a
degree of marked distress in the individual and have at least three of the following five
characteristics: eating large amounts of food when not hungry, eating much more rapidly
than normal, eating until uncomfortably full, eating alone because of embarrassment,
and having feelings of disgust or guilt about the overeating episode. BED also requires
no associated purging behavior related to the binging.2
Several diagnostic scales are available for the evaluation of BED. The Eating
Disorder Examination, Yale-Brown Obsessive-Compulsive Scale Modified for Binge
Eating, the Questionnaire on Eating and Weight Patterns, and the Eating Disorder
Assessment for DSM-V are examples of scales that have been validated for BED. The
time to perform and evaluate these scales can be a limitation to their use in clinical
settings. Utilizing a brief scale for characteristics of BED specified by the DSM-V criteria
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and confirming this with clinician interview can be used clinically in an abbreviated way
to diagnose binge eating disorder.
Anecdotally binge eating episodes occur later in the day. This was observed in
the 170 patients in this trial, although not studied in an observational trial. It is less
common to see binge eating occur early in the day soon after awakening. Binge eating
episodes more commonly occur in-between the mid-day meal and the evening meal,
after the evening meal, or within the meal setting.
Binge eating disorder has a stronger correlation in obesity compared to
individuals with normal weight. Kessler et al reported in the World Mental Health data
base the odds ratio of lifetime prevalence of BED in normal and overweight populations
to be 1.0 and 1.3. In individuals with BMI of 30-34.9 and 35-39.9 the odds ratios rose to
3.1 and 3.0 respectively. In the BMI class of 40 and greater the odds ratio of BED was
6.6. The odds ratio of BED in a study by Hudson et al was 1.9 for a BMI of 30-39.9 and
4.9 for a BMI of 40 or greater. This was a face to face survey of U.S. households of 9282
adults.3 Wadden et al reviewed epidemiologic studies and found the diagnosis of BED in
subjects being assessed for bariatric surgery to range from 5-25% using strict BED
criteria and structured clinical interviews.4
Successfully treating BED is beneficial in both the treatment of weight loss and in
maintenance of weight loss. Treatments of BED currently include cognitive behavioral
therapy and/or the FDA approved medication lis-dexamphetamine.5 Several medications have been used off-label by practitioners for the treatment of BED including
topiramate, phentermine, phentermine-topiramate combinations, bupropion and naltrexone as well as other medications.5 Bariatric surgery has demonstrated effectiveness
in ameliorating BED in patients.6
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CIRCADIAN CHRONOTYPE
The circadian system occurs in all organisms from unicellular to plants to humans. In the last few decades there has been a large advance in understanding of
the molecular elements and functioning of the circadian system.
In humans the circadian system is composed of a central pacemaker located in
the suprachiasmatic nucleus of the hypothalamus that centrally coordinates control of
most physiologic and behavioral functions. Light input from the retinal hypothalamic tract
provides light and dark information that the central pacemaker uses to coordinate
multiple components of physiology into repeating 24-hour cycles. This includes
sleep/wake cycles, hormonal regulation, body temperature control and many of our
metabolic homeostatic systems.
The structure of the circadian architecture is based on a DNA transcriptionaltranslational feedback loop (TTFL) that regulates the circadian clock not only in the
suprachiasmatic nucleus but peripherally the molecular “clock” mechanisms are
replicated in most cells in the human body. Two proteins, CLOCK and BMAL1, are the
core of the clock signaling in humans. They dimerize into a transcription factor that
codes for their own repressors (PER and CRY). PER and CRY dimerize in the
cytoplasm and enter the nucleus to repress the CLOCK:BMAL1 complex. They are
degraded cyclically in the cytoplasm through an ubiquitination process. This creates a
cycling effect of activation and repression that is the basis for the 24-hour circadian
cycle. ROR and REV-ERBa are other looping regulators that control timing and repress
other molecular regulators of the circadian system including several ubiquitases,
phosphatases and kinases. There is also post-translational and post-transcriptional
modulation of the circadian signaling cycles.7
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The circadian system can be modulated by external inputs called Zeitgebers.
Such inputs as timing of sleep, meal timing, and ambient temperature can modulate the
functioning of the clock in the peripheral clocks of cells and organs as well as through
the central pacer in the suprachiasmatic nucleus. Control of the circadian signaling can
also occur through post-translational and post-transcriptional control.7
The awake-sleep cycle in humans is a circadian characteristic known as
chronotype. This cycle can be categorized as early, intermediate or late chronotype depending on an individual’s preferred time of awakening and going to sleep. Individuals
with an early chronotype tend to wake up earlier in the day and have a tendency for
sleep onset earlier in the evening. This is in contrast to individuals with late chronotypes
who have wake and sleep times naturally shifted to later in the day.8
Individuals with different chronotypes not only have preferred sleep and
wakening times but have been shown to have different timing of macronutrient
intakes. Later times of meal ingestion have been shown to affect body composition to a
more obese phenotype. Later meal ingestion has been shown to affect peripheral
circadian signaling as well.9 Animal studies show changes in peripheral and central
circadian signaling and feedback by altered timing of meal ingestion.10 A study in
humans also showed effects on the clock gene PER2 expression in whole blood as a
result of shifted meal timing.11
Chronotype is determined by the rise in melatonin levels that occurs two
hours prior to the normal time an individual has onset of sleep. This can be measured either by determining serum or salivary levels showing the daily rise of melatonin
in the evening. Economically this would be difficult to measure in an outpatient clinical
setting. Chronotype can also be determined using the validated scale Morning Evening-

5

ness Questionnaire (MEQ), which is a self-reported scale which categorizes individuals
through quintiles from a definite morning through a definite evening chronotype.12

CIRCADIAN DYSYNCHRONY
Dysynchrony of the circadian system can have deleterious metabolic effects.
Mouse knock-out models of individual components of the TTFL frequently have obesity
and metabolic dysfunction.13
Meal timing is a circadian zeitgeber, and experimental studies in animals show
shifting times of meal ingestion can result in signs of metabolic syndrome and weight
gain. These results have been seen in human studies as well. Later time of food intake
can lead to less effective weight loss during weight loss trials as well as increased
weight gain. Signs of insulin resistance can be seen in short-term studies that shift
feeding times to later in the day. Late chronotypes have been observed to ingest more
macronutrients later in the day.14
Sleep onset can be a powerful zeitgeber as well, causing dysynchrony in
circadian signaling and human disease. In humans a common example of circadian
dysynchrony is seen in chronic shift workers. In this population of workers, dysynchrony
is associated with increased risks of obesity, cardiovascular disease, metabolic
syndrome, Type 2 diabetes and an increased risk of malignancies. Shift work disorder is
associated with short sleep and frequently shifted time of food ingestions. These
associations may occur without a concurrent increase in calorie intake.15

STUDY PURPOSE
A previous study by Harb et al demonstrated in a cross-sectional study of a
predominately overweight but not obese sample, an association of binge eating disorder with later chronotype.16
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The objective of this study was to assess if there is a relationship between BED
and late chronotype in patients with obesity. If a positive association exists then therapeutic interventions based on an individual circadian chronotype may be beneficial both
in the treatment of BED but also obesity and related comorbidities. A secondary objective was to determine if either the presence or absence of BED and having a late
chronotype has an effect on weight loss outcomes in a 16-week obesity treatment study.
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CHAPTER 2: METHODS
PARTICIPANTS
Retrospective chart analysis was conducted on 170 patients with obesity presenting to Nebraska Bariatric Medicine, an obesity medicine clinic, from July 1, 2017 to
December 31, 2017. The clinic is staffed by a board-certified obesity medicine
physician. Most patients are referred to the clinic by other health care providers and are
treated with behavioral and pharmacologic modalities. Some of the patients are selfreferred. Common reasons for referral into the clinic are medical issues complicated by
obesity such as degenerative joint disease with a need for weight loss prior to joint
arthroplasty, diabetes, obstructive sleep apnea, congestive heart failure and chronic
renal failure. Patients were in the age group of 19-70.

PROCEDURES
The study protocol was approved by the University of Nebraska Medical Center
IRB (482-18-EP) with oversight to the study ceded by Catholic Health Initiatives IRB
(1244485-1). The study population was obtained from Nebraska Bariatric Medicine in
Lincoln, Nebraska which is part of the Catholic Health Initiatives health system.
MEASURES
Chronotype was an independent variable and assessed in all clinic patients at
the initial visit with the MEQ, a patient self-assessment scale. The questionnaire includes
19 questions that determine an individual’s peak time of alertness during their day and
patterns of sleep and wakefulness. Patients were categorized as a late chronotype with
a score of 42 or less on the MEQ. Scores greater than 42 were categorized as a nonlate chronotype.
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BED was diagnosed using a brief written questionnaire completed by the patient.
The questionnaire has the patient rate on a graded scale if he or she experiences
episodes of eating larger amounts of food and has a sense of loss of control during
those eating episodes. Frequency of eating with lack of control is assessed, and a
checklist of confirmatory characteristics is included. Three of these characteristics
during binging need to be present to confirm the diagnosis and include the following:
Eating more rapidly than normal
Eating until uncomfortably full
Eating larger amounts of food when not hungry
Eating alone because of embarrassment
Feeling depressed or guilty about the overeating
Feeling upset about the uncontrolled eating or weight gain

Binging needs to occur at least once of week over the three months prior to the
initial visit. The questionnaire also asks if the patient has any purging behaviors. These
diagnostic criteria from the DSM-V for BED are then confirmed by the physician during
the initial history and physical examination. The questions for chronotype and binge
eating disorder are included on an intake form completed by all clinical patients at their
initial visit.
All participants had initial demographic information including age, BMI calculated
by the Quetelet index (weight in kilograms divided by height in meters squared), blood
pressure, resting heart rate, height and weight. Weight, BMI, blood pressure and resting
heart rate were reassessed after 16 weeks of weight loss treatment in the clinic.
Comorbid conditions of hypertension, insulin resistance, type 2 diabetes, obstructive
sleep apnea and chronic insomnia were also assessed in all patients.
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Treatment consisted of a behavioral intervention plan as well as weight loss
pharmacotherapy in patients if indicated. The behavioral plan included use of a breakfast
meal replacement, monitoring daily diet intake usually using a phone application,
learning to restrain amounts within a meal, and mindful eating patterns. Medications
commonly used in the clinic included phentermine, topiramate, bupropion, naltrexone
and metformin. Patients were scheduled for monthly clinic follow-up for 16 weeks.

STATISTICAL ANALYSES
Descriptive statistics were performed to describe the baseline characteristics
of the study patients. Frequencies were calculated for sex, BED, non-BED, late and nonlate chronotype.
Chi-square analysis was used to evaluate the relationship between BED and
chronotype. The 2-tailed student t test was used to determine if there was a significant
difference in weight change at 16 weeks in the group of patients with or without binge
eating and in the group with late or non-late chronotype.
SPSS version 25.0 (SPSS, Chicago, IL) was used for all analysis. Statistical significance was set at p < 0.05.
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CHAPTER 3: RESULTS
The patients (n = 170, range 19-70) had a mean age of 49.1 years (S.D. 11.7).
80% of the patients were female and 20% male. In the study population 67.1% had
insulin resistance, 47.9% had obstructive sleep apnea, 50.0% were treated for
hypertension and 23.5% had type 2 diabetes mellitus. Self-reported hours of sleep by
the patients was recorded and 57.4% of the patients reported 7 hours of sleep a night or
more.
In the study population 41.2% of the patients were diagnosed with BED and
58.8% did not have BED. Late chronotype was seen in 12.1% of the sample and 87.9%
had a non-late chronotype. Descriptive characteristics are shown in Table 1.
Table 1
Demographic characteristics of the sample population (N = 170)
Patient characteristics

Mean (S.D.)

Age (years)
49.1 (11.7)
Sex—n (%)
Female
136 (80.0%)
Male
34 (20.0%)
Weight—lbs.
281.4 +/- (65.9)
Body mass index (kg/m2)
45.1 +/- (9.0)
Initial weight
Female
268.0 +/- (4.6)
Male
334.6 +/- (14.2)
BED—n (%)
70 (41.2)
Non-BED—n (%)
100 (58.8)
Initial weight BED
279.0 +/- (7.9)
Initial weight non-BED
283.0 +/- (6.62)
MEQ
55.5 +/- (11.1)
Initial weight late chronotype
291.3 +/- (54.8)
Initial weight non-late chronotype
282.3 +/- (69.2)
Insulin resistance—n (%)
56 (32.9)
Initial weight IR
290.3 +/- (71.3)
Initial weight non-IR
263.2 +/- (49.0)
Obstructive sleep apnea—n (%)
81 (47.6)
Initial weight with OSA
309.3 +/- (8.2)
Initial weight without OSA
256.2 +/- (4.8)
Hypertension—n (%)
85 (50)
Type 2 DM—n (%)
40 (23.5)
Initial weight with T2DM
301.3 (14.2)
Initial weight without T2DM
274.2 (4.9)
Sleep > 7 hours n (%)
97 (57.4%)
Initial weight with sleep > 7 hours
284.1 +/- (7.1)
Initial weight with sleep < 7 hours
278.8 +/- (7.2)
_____________________________________________________________________________
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There was no significant difference in either BED or late chronotype with the presence or
absence of IR, OSA or T2DM.
Two patients were not included in the analysis of BED with chronotype due to
incomplete data. The MEQ was not completed in these patients. For 168 patients who
were evaluated for BED and had completed the MEQ, Pearson Chi-square analysis was
performed to evaluate their relationship. The 2-sided significance had a p value of .412
which demonstrated no significance incidence for BED and late chronotype. Table 2

Table 2
Pearson’s chi-squared test for frequencies of BED and chronotype
MEQ #
______________________non-late_________late_________ Total____
BED #

57

6

63

Non-BED #

74

12

86

131

18

149

Total

_____________________________________________________________

_____________________Value
Pearson Chi-Square
.672

Significance
_______df_____________(2-sided)____
1
.412
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Out of the 170 patients initially evaluated, 149 had 16-week follow-up visits. For
the secondary outcome of weight loss change at 16 weeks, weight change outcome data
was available for a completers rate of 87.6%. The degree of weight loss was evaluated
using student t tests in both those with and without BED and in those with late and nonlate chronotypes. There was no significant difference between groups for either BED or
chronotype categories. Student t test evaluating weight change at 16 weeks in those
with BED and without BE showed no significance with a p value of .435. The difference
in means between those with and without late chronotype and weight change at 4
months trended closer but was not significant with a p value of 0.107. Tables 3 and 4

Table 3
16-week weight loss

Mean (S.D.)

Initial Body Mass Index (kg/m2)
16-week Body Mass Index (kg/m2)

45.1 +/- (9.0)
42.4 +/- (9.2)

Initial weight lbs.
281.4 +/- (65.9)
16-week weight lbs.
267.9 +/- (70.0)
Weight change 16 weeks
in BED lbs.
17.2 +/- (2.1)
Weight change 16 weeks
in non-BED lbs.
16.3 +/- (1.60)
Weight change 16 weeks
in late chronotype lbs.
12.1 +/- (4.8)
Weight change 16 weeks
in non-late chronotype lbs.
17.4 +/- (1.4)
___________________________________________________________
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Table 4
Independent samples test for weight loss difference in BED

Number
BED
Non-BED

50
61

Mean %
weight change
.063
.056

% weight change (significance 2-tailed
(equal variances assumed)

Standard
deviation
.051
.041

.435

Independent samples test for weight loss difference in chronotypes

Number
Late chronotype
Non-late
chronotype

Mean %
weight change

Standard
deviation

11

.038

.047

89

.063

.046

% weight change (significance 2-tailed
(equal variances assumed)

.107

There was no significant difference in 16-week weight loss in the analysis of the
groups with and without IR, OSA and T2DM or hypertension (significance with 2-tailed
independent t test 0.45, 0.15, 0.18 and 0.38 respectively).
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CHAPTER 4: DISCUSSION
The primary outcome in this study was an evaluation of the relationship between
BED and late chronotype in a population of patients with obesity presenting for treatment. There was not an increased incidence of BED in patients with a later chonotype.
The secondary outcome of the study evaluated the weight loss outcomes in this
population at 16 weeks. There was no significant difference in weight loss whether the
patients had BED or not and there was no effect of weight loss outcomes with the
different chronotypes.
This is in contrast with the study by Harb et al, which did show a correlation
with increased BED in subjects with a later chronotype. That study included
a smaller sample of 100 subjects who presented to a nutrition clinic. Of the subjects in
that study 66% were overweight and 18% met criteria for obesity. The rate of BED was
14.5% using the Binge Eating Scale. This study was in a population of only patients with
obesity. The Harb study was a cross-sectional trial and no evaluation of weight change
was studied.
The present study does have several limitations. The sample size was 170
patients but the number with late chronotype was low, slightly greater than 12%. Two
patients in this trial did not complete the MEQ and 168 patients were compared with
BED and chronotype.
For the secondary outcome of weight change only 87.6% of the patients had
follow-up weights at 16 weeks. BED was diagnosed differently in the two studies. The
Binge Eating Scale was utilized in the Harb study and clinician confirmation of BED
based on DSM-V criteria used in this study. The Harb study had a BED incidence of
14.5% versus 41.2% in this study. This may reflect the differing populations as the
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patients in this study were primarily referred to this clinic for significant obesity and
comorbid problems. Increasing BMI is associated with increasing likelihood of BED.
Different diagnostic methods may also have affected the different rates of BED.
An important outcome in this study did show that diagnosis of BED or late
chronotype did not cause a difference in weight loss. The patients were all evaluated
and treated with the same behavioral program but differed in pharmacologic treatment.
In general patients with BED tended to be treated more frequently with topiramate
versus those without BED. The completers that had 16-week follow-up data was only
87.6% and several of these patients eventually returned for follow-up at a later date.
Retention is difficult in an obesity medicine clinic and patients are not always compliant
with follow-up visits. Weight loss in a short-term trial such as this does not reflect longterm weight loss or weight loss maintenance.
Repeating the study with a larger sample of patients and all participants having a
similar pharmacologic treatment plan could improve on the limitations of this study.
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CHAPTER 5: CONCLUSION
There is not an increase in BED in patients with late chronotype in a population
of patients with obesity or overweight in this retrospective analysis. In a 16-week trial
the amount of weight loss attained by these patients did not vary whether the subjects
had BED or had a late chronotype.
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